平特五不中

Home

Crossing the blood-brain barrier to treat MS

18 Jun 2024

A clinical trial at The Neuro is targeting immune cells deep in the brain to slow disease progression.

Making progress against MS progression

28 May 2024

Researchers have developed drugs that improve the outlook for millions of patients.

It's MS Awareness Month!

14 May 2024

Your monthly update from The Neuro-Patient Resource Centre

New insights into what makes multiple sclerosis worse and how to make it better

Published: 28 June 2023

Scientists identify the first genetic marker for MS severity, opening the door to treatments for long-term disability ...

Finding the light

13 Jul 2023

Seven years ago, after a week of unbearable migraines, Brett Murphy was lying in a hospital bed seeing the world in blurry black and white.

Living a full life with multiple sclerosis

11 May 2022

An avid skier, Pierre Lachance doesn鈥檛 let multiple sclerosis stop him from hitting the slopes higher, faster and harder.

Portaging for MS research

18 Oct 2021

F茅lix Jasmin translated his lifelong love of canoeing and the outdoors into an ambitious fundraising challenge, one that has raised over half a million dollars to fight multiple sclerosis.

New frontiers in MS research

7 May 2021

Patients are the key to the success of new projects at The Neuro that could greatly help in treating multiple sclerosis and understanding its cause.

Using AI to support treatment decisions in MS

21 Apr 2021

Dr. Douglas Arnold is the recipient of the $1 million Artificial Intelligence (AI) & MS Discovery Grant supported by TD Bank Group through the TD Ready Commitment....

Pages

Subscribe to Multiple Sclerosis RSS

The Neuro logo听平特五不中 logo

听

The Neuro (Montreal Neurological Institute-Hospital)听is a bilingual academic healthcare institution. We are a听平特五不中 research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the 平特五不中 Health Centre.听We are听proud to be a Killam Institution, supported by the Killam Trusts.

听

听

Back to top